title: Polymorphisms in mTORC1 genes modulate risk of esophageal squamous cell carcinoma in eastern Chinese populations.
abstract: BACKGROUND
  Mammalian target of rapamycin complex 1 (mTORC1) is an evolutionary conserved multiprotein complex that functions as a key regulator of gene transcription, protein translation, and autophagy. No studies have assessed associations between functional single nucleotide polymorphisms (SNPs) in mTORC1 genes and risk of esophageal squamous cell carcinoma (ESCC).
  
  
  METHODS
  : In a case-control study of 1126 ESCC patients and 1131 cancer-free controls, we genotyped eight SNPs in mTORC1 (mTOR rs1883965 G>A and rs2536 T>C, mLST8 rs3160 C>T and rs26865 G>A, RPTOR rs3751934 C>A, rs1062935 T>C, rs3751932 T>C and rs12602885 G>A) and assessed their associations with risk of ESCC.
  
  
  RESULTS
  In the single-locus analyses, we found a significantly altered risk of ESCC associated with mTOR rs1883965 A variant genotypes (adjusted OR = 1.27 and 1.26; 95% confidence interval = 1.01-1.60 and 1.01-1.58 for GA and GA/AA, respectively, compared with GG) but not with other SNPs. In the combined analysis of the eight SNPs, we found individuals with two or more unfavorable genotypes exhibited an increased risk for ESCC (adjusted OR = 1.35; 95% confidence interval = 1.20-1.62), compared with those with less than two unfavorable genotypes. Such a cumulative effect was dose-dependent (ptrend = 0.004). In the multiple dimension reduction analysis, mTOR rs1883965 was consistently suggested as the strongest individual factor for ESCC risk, and the model including all SNPs yielded the lowest prediction error of 17.66% for model validation.
  
  
  CONCLUSIONS
  These findings suggest that functional SNPs of mTORC1 genes may individually or collectively contribute to ESCC risk. Further validation of these findings is warranted.
authors.affiliation: Cancer Institute, Fudan University Shanghai Cancer Center, and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
authors.forename: Mei-Ling
authors.initials: ML
authors.lastname: Zhu
authors.forename: Hongping
authors.initials: H
authors.lastname: Yu
authors.forename: Ting-Yan
authors.initials: TY
authors.lastname: Shi
authors.forename: Jing
authors.initials: J
authors.lastname: He
authors.forename: Meng-Yun
authors.initials: MY
authors.lastname: Wang
authors.forename: Qiao-Xin
authors.initials: QX
authors.lastname: Li
authors.forename: Meng-Hong
authors.initials: MH
authors.lastname: Sun
authors.forename: Li
authors.initials: L
authors.lastname: Jin
authors.forename: Ya-Jun
authors.initials: YJ
authors.lastname: Yang
authors.forename: Jiu-Cun
authors.initials: JC
authors.lastname: Wang
authors.forename: Jia-Qing
authors.initials: JQ
authors.lastname: Xiang
authors.forename: Qing-Yi
authors.initials: QY
authors.lastname: Wei
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000209:etiology*; D016022:Case-Control Studies; D002681:China / Q000453:epidemiology; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D008297:Male; D000076222:Mechanistic Target of Rapamycin Complex 1; D008875:Middle Aged; D046912:Multiprotein Complexes / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011379:Prognosis; D012307:Risk Factors; D058570:TOR Serine-Threonine Kinases / Q000235:genetics*
chemical_list: D046912:Multiprotein Complexes; D000076222:Mechanistic Target of Rapamycin Complex 1; D058570:TOR Serine-Threonine Kinases